Skip to content

Diaphragmatic Echography in COVID-19 Pneumonia

Prognostic Value of Transthoracic Diaphragmatic Echography in COVID-19 Pneumonia Patients With Acute Respiratory Failure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05805579
Acronym
COVIDUSDIAP
Enrollment
171
Registered
2023-04-10
Start date
2021-02-01
Completion date
2021-06-20
Last updated
2023-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia, Viral, Covid19, Respiratory Failure

Keywords

COVID19 pneumonia, Diaphragm ultrasound

Brief summary

We hypothesized that diaphragm thickness is concerned in acute respiratory failure of COVID19 patients and its ultrasound measure at the begining of hospitalisation is a good predictor of poor outcome. A prospective observational non intervention study is designed.

Detailed description

To answer our hypothesis we will perform diaphragm ultrasound in the first 24hr hospitalized COVID19 patients. In the ultrasound exploration we will assess diaphragm movility and thickness. We will also assess other clinical, biochemistry and radiological variables. The main outcome we want to analyze is the destination on discharge: home, respiratory intermediate critical unit or exitus.

Interventions

Diaphragmatic echography

Sponsors

Sociedad Aragonesa de Patología del Aparato Respiratorio
CollaboratorUNKNOWN
Javier Lázaro
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* COVID19 Pneumonia Acute respiratory failure (PaO2 \<60mmHg)

Exclusion criteria

* Invasive or non invasive ventilation within first 24h Neuromuscular disease Diaphragmatic paralysis

Design outcomes

Primary

MeasureTime frameDescription
Early diaphragm ultrasound as a predictor factor for invasive and non invasive ventilation and deathFrom date of inclusion until discharge date (lenght of hospitalization)This is the main outcome of our study given that it has a important clinical implications. If we confirm our hypothesis diaphragm ultrasound could prove to be a useful prognosis tool for COVID19 patients.

Secondary

MeasureTime frameDescription
Diaphragm thickness rate as a predictor factor for invasive and non invasive ventilation and deathFrom date of inclusion until discharge date (lenght of hospitalization)Diaphragm strenght is directly related to thickness. The impact of COVID19 infection on this specific measure can predict patient evolution.
Diaphragm movility rate as a predictor factor for invasive and non invasive ventilation and deathFrom date of inclusion until discharge date (lenght of hospitalization)Diaphragm fatigability is directly related to movility. The impact of COVID19 infection on this specific measure can predict patient evolution.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026